Cellvizio, advanced endomicroscopy technology from Mauna Kea Technologies, allows surgeons to rule out precancerous or cancerous cells prior to performing anti-reflux surgery. “Instead of taking biopsy tissue to a microscope to identify cancer in patients with GERD, with Cellvizio we are taking the microscopy to the tissue,” said V. John Bagnato, MD, a surgeon at Coliseum Northside Hospital.
More articles on gastroenterology:
3 devices designed to improve CRC detection rates & care
How has healthcare reform affected gastroenterology?
3 GI/endoscopy coding & billing tips
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
